Oric Pharmaceuticals, Inc. (ORIC)
12.62
-0.24
(-1.87%)
USD |
NASDAQ |
Sep 08, 16:00
12.50
-0.12
(-0.95%)
Pre-Market: 08:25
Oric Pharmaceuticals Net Income (Quarterly) : -41.49M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -41.49M |
| March 31, 2026 | -35.77M |
| December 31, 2025 | -30.50M |
| September 30, 2025 | -32.59M |
| June 30, 2025 | -36.36M |
| March 31, 2025 | -30.02M |
| December 31, 2024 | -36.31M |
| September 30, 2024 | -34.57M |
| June 30, 2024 | -31.96M |
| March 31, 2024 | -25.01M |
| December 31, 2023 | -28.33M |
| September 30, 2023 | -25.48M |
| June 30, 2023 | -22.94M |
| March 31, 2023 | -23.94M |
| December 31, 2022 | -20.85M |
| Date | Value |
|---|---|
| September 30, 2022 | -24.83M |
| June 30, 2022 | -20.29M |
| March 31, 2022 | -23.16M |
| December 31, 2021 | -22.77M |
| September 30, 2021 | -18.43M |
| June 30, 2021 | -21.01M |
| March 31, 2021 | -16.51M |
| December 31, 2020 | -28.26M |
| September 30, 2020 | -25.55M |
| June 30, 2020 | -11.02M |
| March 31, 2020 | -8.872M |
| December 31, 2019 | -8.354M |
| September 30, 2019 | -6.549M |
| June 30, 2019 | -5.965M |
| March 31, 2019 | -6.015M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 41.49M |
| EPS Diluted (Quarterly) | -0.3841 |
| Enterprise Value | 1.046B |
| Earnings Yield | -10.70% |
| Normalized Earnings Yield | -10.70 |